It's June and that makes it BIO International month! The Evaluate team is preparing for a busy few days in Boston. Come and find us at booth #1879 or in the partnering system for a chat about the latest pharma trends and all your business development, licensing and portfolio strategy challenges. See you there! 🤝 https://lnkd.in/eEDtKaAK
Evaluate Ltd
Information Services
Evaluate provides trusted commercial intelligence and predictive analytics to the pharmaceutical industry
About us
Evaluate provides trusted commercial intelligence and forecasting models for the pharmaceutical industry. We help our clients to refine and transform their understanding of the past, present and future of the global biopharma market to drive better decisions. Evaluate solutions give you the time and confidence to turn understanding into insight, and insight into action. Evaluate Pharma - the trusted global view of the pharmaceutical market’s past, present and future performance with consensus forecasts to 2030, company financials, pipelines, deals and more. Evaluate Omnium - provides a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, delivering game-changing insight into pharma asset potential. Forecasting Solutions - Ensure precise and efficient forecasting at every stage of your product lifecycle. Our comprehensive suite of forecasting solutions tailored to the pharmaceutical industry, including software, cloud-based platforms, custom-built models, advanced analytics and data. Our forecasting solutions support forecasters through new product planning, launch, and commercialisation. CDMO Intelligence - Access CDMO screening, molecular landscape insights, detailed manufacturing capabilities, and accurate volume forecasts. You’ll have a wealth of data and industry insights at your fingertips, backed by gold standard financial forecast methodologies. Consulting and Analytics - Evaluate’s consulting and analytics team is here to help clients address unique scientific, clinical and commercial challenges. We answer key asset, portfolio strategy, and corporate strategy-related business questions, powered by the combined resources of Norstella, one of the world’s largest pharma intelligence solutions providers. Evaluate’s combination of leading data sources, deep pharma expertise, robust methodologies, data science and real-world data will ensure your teams make the right decisions to drive your growth.
- Website
-
http://www.evaluate.com
External link for Evaluate Ltd
- Industry
- Information Services
- Company size
- 51-200 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 1996
- Specialties
- pharma business analysis, pharma licensing deals, pharma consensus forecasts, biotech business analysis, pharma competitive intelligence, medtech consensus forecasts, pharma business developement, pharma R&D analysis, pharma data, pharma forecasting models, Real World Data, Pharma portfolio strategy, Pharma Consulting, and BD&L consulting
Locations
-
Primary
Get directions
3 More London Riverside
London, SE1 2RE, GB
-
Get directions
60 State St
Boston, Massachusetts 02109, US
-
Get directions
Akasaka Garden City 4F, 4-15-1 Akasaka,
Tokyo, Tokyo 107-0052, JP
Employees at Evaluate Ltd
Updates
-
【講演 満員御礼】 本日 #MDMD 2025 （Medinew Digital Marketing Day（MDMD）2025 Summer）にて、マーケティング・製品戦略に携わる皆さまへ「医薬品の売上予測」に関する講演を実施しました✨ 講演では、「売上予測に透明性を」タイトルのもと、医薬品売上予測業務における製薬企業の課題をもとに、データドリブンな解決事例をご紹介いたしました。 満席でのご参加、誠にありがとうございました！ 今後とも、#Evaluate を何卒よろしくお願いいたします。 #MDMDセミナー #売上予測 #医薬品 🔎医薬品予測についてはこちらから＞ https://vist.ly/3n523rh
-
-
🧭 Forecasting the future requires the right tools. https://ow.ly/GwXc50VNRL3 Evaluate’s Long-Range Planning Content Hub offers a comprehensive suite of resources to help you with your forecasting approach. Visit the hub at the link in this post to check it out.
-
🔹【ウェブサイトリニューアルのお知らせ】🔹 製薬業界の商業化・売上予測に関する専門コンテンツをさらに強化しました。 このたび、エバリュエートは公式ウェブサイトを全面的にリニューアルいたしました。 新サイトでは、ユーザー体験の向上に加え、以下のような新機能・強化ポイントを実装しています： ● 医薬品の #商業化戦略 / #売上予測 / #ライセンシング 動向に関するコンテンツ拡充 ● 最新トレンドや分析を紹介するインサイト記事の定期配信 ● ウェビナー・イベント情報へのアクセス性向上 ● #BD&L （#事業開発 /ライセンシング）に役立つ実践的リソースの提供 新しいエバリュエートのウェブサイトはこちらからご覧いただけます： 👉 https://vist.ly/3n5xdx7
-
-
Join our expert analysts, Anna Simmons and Neha Anand as they break down the major announcements, clinical trial results and emerging therapies from this year’s ASCO Meeting. 📅 Register now for the webinar: https://lnkd.in/eiSjtQjY What you’ll gain: 🔍 Comprehensive highlights 📊 Strategic analysis 🌍 Market implications #ASCOAnnualMeeting #Oncology
-
-
Evaluate Ltd reposted this
🚀 We're Hiring: Director of Product Management at Evaluate Ltd, a Norstella company 🚀 Are you obsessed with data, product vision, and driving real impact in healthcare and financial services? This is your chance to shape the future of how life sciences and financial services make smarter, faster decisions! At Evaluate, we're not just crunching numbers; we're turning data into insight, and insight into action. You’ll lead the charge in managing high-value datasets, defining roadmap strategy, and delivering innovative solutions powered by AI/ML 🔑 What's in it for you: ✅ Own the product strategy from end to end ✅ Collaborate with brilliant minds across Sales, Marketing, R&D, Finance, Technology, Data Science and Data Ops ✅ Influence how pharma + financial services connect to data ✅ Drive innovation through AI/ML integration and advanced analytics What we need: ✅ Strong understanding of equity research, financial markets, and investment workflows ✅ Proven experience in product management & strategy within data-rich environments ✅ Excellent leadership and communication skills ✅ Ability to translate complex data into actionable insights for clients If you're passionate about leveraging data to improve patient access to life-changing therapies, we want to hear from you! Norstella Evaluate Ltd Citeline Panalgo The Dedham Group MMIT (Managed Markets Insight & Technology) https://lnkd.in/gypURGhD
-
Forecasting starts with understanding the population. https://vist.ly/3n5mied Epidemiological data is the backbone of early-stage forecasting, especially when mapping unmet needs or sizing new markets, but turning complex data into clear decisions? That takes structure. Our eBook breaks down how to use epidemiological data the right way so your forecasts stay grounded and strategic. Download now at the link in this post.
-
-
If your forecast could talk, would it sound confident or confused? https://vist.ly/3n5ivr6 Whether you're deep in launch planning or refining in-market performance, it’s all about using the right best practices for your chosen methodology. That’s why we created The Methodology Trilogy - a practical eBook that helps you sharpen your approach, no matter which model you're using: · Epidemiology · Patient flow · Sales-based Find tips, frameworks, and examples you can actually use. Grab your copy at the link in this post.
-
-
The latest quarterly outlook report has arrived from Biomedtracker! Plan for the drugs, deals and catalysts expected to shape Q2 in our latest quarterly outlook report. Download now! https://ow.ly/qzhM50VSUBz
-
📣Calling all out-licensing professionals in biotech!📣 Our friends at Inpart are running their annual biopharma survey and we'd love to have your input. The survey will help uncover: 🔹 The toughest challenges in finding and securing the right partners 🔹 How AI is beginning to influence partnering strategy 🔹 Which channels are most effective for connecting with potential collaborators 📩 Ready to start? The survey is here → https://lnkd.in/eVGCiF6r All responses are anonymous and will feed into next year’s Partnering 2030 Report which will help the life sciences community benchmark progress and highlight how partnering can become more efficient, transparent, and successful.
-